Page 2 - Imanis Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ENewsChannels NEWS: -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine. :: News from eNewsChannels

Rochester's Imanis Life Sciences has been tracking patients' immunity to COVID-19 since early in the pandemic. Now the firm is adding a new test to its arsenal to tally the neutralizing antibodies that protect against the omicron variant of the virus.

Twenty years is a long time to watch a city’s landscape evolve and change as businesses succeed and fail along with the people behind the projects.

Immunocompromised Washington, D.C., attorney Samuel Shafner was unsure of his risks, even though he was vaccinated. A desire for more detailed answers about his immunity led him to Rochester's Imanis Life Sciences and its Immuno-Cov test.

We round up more than 60 founders of Minnesota-based startups who gained experience at a big company in town.